RespireRx Pharmaceuticals Inc.
RSPI
$0.0021
$0.0011110.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -395.50K | -681.00K | -430.10K | -289.70K | -472.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 125.00K | 4.50K | 6.50K | 8.50K | 45.60K |
| Total Other Non-Cash Items | -8.40K | -10.10K | -27.60K | 176.60K | -9.00K |
| Change in Net Operating Assets | 177.90K | 558.00K | 421.90K | 115.70K | 366.00K |
| Cash from Operations | -101.00K | -128.60K | -29.20K | 11.20K | -69.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 65.80K | 29.20K | 8.40K | 109.40K |
| Total Debt Repaid | -- | -- | -- | -19.50K | -37.90K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 100.00K | 70.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.50K |
| Cash from Financing | 100.00K | 135.80K | 29.20K | -11.10K | 70.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.00K | 7.20K | 100.00 | 0.00 | 0.00 |